MedPath

Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons

Not Applicable
Completed
Conditions
Cardiovascular Disease
Dietary Modification
Cardiovascular Risk Factors
Interventions
Other: unsaturated fat for saturated fat
Other: saturated fat
Registration Number
NCT02589769
Lead Sponsor
Oslo University Hospital
Brief Summary

A randomized controlled clinical trial comparing the effect of substitution of unsaturated fat from nuts and oils for saturated fat from meat and dairy foods on serum lipids in normal weight and obese subjects with elevated LDL cholesterol.

Detailed Description

Background: Increased intake of saturated fat may influence LDL cholesterol and other cardiovascular risk factors different in normal weight and obese subjects. Methods: The study is a randomized controlled clinical trial in 84 men and women between 21 to 70 years with normal BMI (25 kg/m2) or obesity (BMI 30-45 kg/m2) and elevated LDL cholesterol (\>3.0 mmol/l). Dietary intervention: Randomization will be to one of two balanced weight maintenance Mediterranean-type diets that differ in their fat sources: an intervention diet substituting unsaturated fats from oil and nuts for saturated fats from meat and dairy foods, and a control diet with whole fat dairy and meat with saturated fats that are not fat reduced.

Primary research question: Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat from meat and dairy foods on serum lipids in normal weight and obese subjects with elevated LDL cholesterol.

Secondary research questions: Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat on cardiometabolic risk factors including insulin resistance, inflammation and serum PCSK9 in normal weight and obese individuals.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
83
Inclusion Criteria
  • Men and women aged 21 to 70 years with normal BMI (25 kg/m2) or obesity (BMI 30-45 kg/m2) and elevated LDL cholesterol (> 3.0 mmol/l).
Exclusion Criteria
  • Diabetes types 1 and 2
  • History of CVD including myocardial infarction, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), stroke, transient ischemic attack (TIA) or other atherosclerotic disease, eating disorder and other secondary causes of hyperlipidemia.
  • Use of statins or other cholesterol-modifying drugs.
  • Genetic lipid disorder.
  • Gastrointestinal disorders that limit food choices.
  • Psychiatric illness, drug or alcohol abuse.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
unsaturated fatunsaturated fat for saturated fatan intervention diet substituting unsaturated fats from oil and nuts for saturated fats from meat and dairy foods
saturated fatsaturated fata control diet with whole fat dairy and meat with saturated fats that are not fat reduced.
Primary Outcome Measures
NameTimeMethod
Serum lipids in normal weight and obese subjects with elevated LDL cholesterol.10 weeks

Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat from meat and dairy foods on serum lipids in normal weight and obese subjects with elevated LDL cholesterol.

Secondary Outcome Measures
NameTimeMethod
C-reactive protein in normal weight and obese individuals10 weeks

Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat on c-reactive protein in normal weight and obese individuals

Fasting glucose and HbA1C10 weeks

Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat on fasting glucose and HbA1C

Serum PCSK9 in normal weight and obese individuals10 weeks

Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat on inflammation in normal weight and obese individuals

Trial Locations

Locations (1)

Oslo Universitetssykehus, Ullevål

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath